Vazyme Attends Medica 2021 in Germany to Accelerate Its Global Market Expansion
PR93182
DUSSELDORF, Germany, Nov. 19, 2021 /PRNewswire=KYODO JBN/ --
Chinese biotechnology company Vazyme (688105.SH) recently attended Medica 2021
in Germany—one of the world's largest events for the medical sector—to
accelerate the expansion of its international business. At the event, Vazyme
introduced its newest 3-in-1 virus testing solutions, SARS-CoV-2 Ag & FLU A/B
Rapid Test and SARS-CoV-2, Influenza A/B RT-QPCR Detection Kit and both gained
widespread attention from visitors. The booth attracted more than 500 visitors
including agents and distributors from Germany, Czech Republic, Switzerland,
and Bulgaria, reaching preliminary agreement on cooperation with many of them.
"While rapidly responding to the pandemic and developing an entire series of
industry-leading COVID-19 testing solutions that enable rapid and accurate
results, we have also continued broader efforts to grow our business presence
around the world," said Dr. Tang Bo, the Co-Founder and GM of Medical Division
of Vazyme. "EU is an important market for us and we are dedicated to customer
service with extensive local operations installed to better serve our local
customers." Tang added.
As the world prepares to reopen, high quality, rapid and holistic diagnostic
solutions for COVID-19 will play a critical role in the battle against the
virus. Vazyme designed its effective screening tools—SARS-CoV-2 & FLU A/B
RT-QPCR Detection Kit for nucleic acid detection and SARS-CoV-2 & FLU A/B Ag
Rapid Test—for the simultaneous detection of three types of viruses causing
COVID-19, Flu A, and Flu B. The tests are fast, reliable, and capable of
delivering highly accurate results 'while you wait'.
The company will receive CE marking approval for its SARS-CoV-2 Antigen
Detection Kit (For Self-testing) and the kit will be soon available as
home-tests in European markets. The real time Antigen Detection Kit is capable
of detecting several variants of COVID-19 including delta variant, the most
contagious form of the coronavirus.
By following simple instructions, individuals can conveniently perform a
self-test from the comfort of their home or anywhere. The rapid and portable
testing solution help to prevent asymptomatic transmission, control the spread
of coronavirus in the community and reduce the pressure on local health systems
by quickly identifying individuals with the highest potential to be infectious.
The performance of Vazyme's COVID-19 testing products was fully validated by
several accredited European laboratories including Paul Ehrlich Institute,
Locus Medicus, Alabiso Lab, and others. Vazyme is continually partnering with
world-leading academic institutions, laboratories, and healthcare distributors
in overseas markets to optimize localized sales and distribution networks,
ensuring the company's global users receive the tests and care they need.
As an innovator in technology, Vazyme sees its continuous investment in the R&D
of innovative solutions as a top priority, which ensures the company's
capabilities in developing new products with innovative technologies and
ability to continue to build a comprehensive product portfolio to address the
various needs of global customers.
About Vazyme
Founded in 2012, Nanjing Vazyme Biotech Co., Ltd is one of the few R&D-focused
innovative biotechnology firms in China that has capabilities in developing
upstream technologies in-house and manufacturing finished products. With an
ongoing commitment to innovation and based on its proprietary key generic
technology platform, the company has built a business network spanning
biological research, in vitro diagnosis and biomedicine. Vazyme has developed
eight series of proprietary POCT diagnostic reagents and related control
materials covering cardiovascular and cerebrovascular diseases, inflammation,
prepotency, gastric functions, autoimmunity, renal functions, chronic disease
management as well as respiratory diseases.
For more information, please visit http://www.vazyme.com
Source: Vazyme
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=408151
Caption: Vazyme’s booth attracted many visitors at Medica 2021
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。